Anti-NAPEPLD antibodies are used in the immunodetection of the protein N-acyl phosphatidylethanolamine phospholipase D. In humans, the canonical protein has a reported length of 393 amino acid residues and a mass of 45.6 kDa. Its subcellular localization is in the nucleus, golgi, and membrane. It is widely expressed across many tissue types. A member of a the NAPE-PLD protein family, NAPEPLD is reported to be a D-type phospholipase that hydrolyzes N-acyl-phosphatidylethanolamines (NAPEs) to produce bioactive N-acylethanolamines/fatty acid ethanolamides (NAEs/FAEs) and phosphatidic acid. Synonyms for this target antigen include N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D and NAPE-hydrolyzing phospholipase D.